Shorla
Orlaith Ryan is Co-Founder, CTOand board member of Shorla Oncology (‘Shorla’) a Ireland-US development andcommercial speciality pharmaceutical company.
Orlaith Co-founded Shorla withSharon Cunningham in 2018. The company has raised $45 million to date and hasfour FDA approved cancer treatments commercialised on the US market.
Orlaith brings over 15 years’ experience inregulatory affairs and oncology drug development. She is also a CharteredScientist, governance expert, and educator in regulatory affairs across Europe.
